Ernest Choy

1995–2026 年に発表

143
論文数
26,866
被引用数
86
h 指数
138
i10 指数

被引用数

Ernest Choy の年別被引用数1977 年: 被引用 1 件1992 年: 被引用 1 件1996 年: 被引用 5 件1997 年: 被引用 16 件1998 年: 被引用 10 件1999 年: 被引用 14 件2000 年: 被引用 7 件2001 年: 被引用 10 件2002 年: 被引用 33 件2003 年: 被引用 47 件2004 年: 被引用 56 件2005 年: 被引用 51 件2006 年: 被引用 80 件2007 年: 被引用 100 件2008 年: 被引用 99 件2009 年: 被引用 133 件2010 年: 被引用 195 件2011 年: 被引用 186 件2012 年: 被引用 169 件2013 年: 被引用 173 件2014 年: 被引用 205 件2015 年: 被引用 219 件2016 年: 被引用 208 件2017 年: 被引用 216 件2018 年: 被引用 220 件2019 年: 被引用 781 件2020 年: 被引用 920 件2021 年: 被引用 1,006 件2022 年: 被引用 814 件2023 年: 被引用 685 件2024 年: 被引用 1,082 件2025 年: 被引用 508 件2026 年: 被引用 21 件1978〜1991 年は被引用が無いため表示していません1993〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,229 件、この内訳の 17.9%イギリス: 引用元論文 1,261 件、この内訳の 10.1%中国: 引用元論文 830 件、この内訳の 6.7%ドイツ: 引用元論文 657 件、この内訳の 5.3%イタリア: 引用元論文 642 件、この内訳の 5.2%フランス: 引用元論文 531 件、この内訳の 4.3%カナダ: 引用元論文 530 件、この内訳の 4.2%オランダ: 引用元論文 500 件、この内訳の 4%スペイン: 引用元論文 472 件、この内訳の 3.8%日本: 引用元論文 411 件、この内訳の 3.3%オーストラリア: 引用元論文 332 件、この内訳の 2.7%スウェーデン: 引用元論文 287 件、この内訳の 2.3%
0%17.9%その他 30.2%

分野

  • Medicine75.1%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Immunology and Microbiology7.5%
  • Neuroscience2.4%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Health Professions0.8%
  • その他3.4%

トピック

  • Rheumatoid Arthritis Research and Therapies12.1%
  • Fibromyalgia and Chronic Fatigue Syndrome Research4.8%
  • Spondyloarthritis Studies and Treatments4.6%
  • Systemic Lupus Erythematosus Research3.6%
  • Autoimmune and Inflammatory Disorders Research3.3%
  • Musculoskeletal pain and rehabilitation2.9%
  • その他68.7%

共著者

全論文

検索で開く
  1. EULAR revised recommendations for the management of fibromyalgia

    著者: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 被引用: 1,502

  2. EULAR definition of difficult-to-treat rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 被引用: 539

  3. Translating IL-6 biology into effective treatments

    著者: , , , , , - Nature Reviews Rheumatology 2020 被引用: 697

  4. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 被引用: 279

  5. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis - The Lancet 2021 被引用: 315

  6. Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2019 被引用: 416

  7. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 被引用: 276

  8. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 326

  9. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

    著者: , - Seminars in Arthritis and Rheumatism 2020 被引用: 313

  10. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

    著者: , , , , , , - Seminars in Arthritis and Rheumatism 2020 被引用: 215

  11. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

    著者: - Lara D. Veeken 2012 被引用: 832

  12. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

    著者: , , , , , , , , - Neuromuscular Disorders 2004 被引用: 937

  13. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 276

  14. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

    著者: , - New England Journal of Medicine 2001 被引用: 2,258

  15. Clinical significance of Janus Kinase inhibitor selectivity

    著者: - Lara D. Veeken 2018 被引用: 283

  16. Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases

    著者: , , , , , , , , , - Lara D. Veeken 2023 被引用: 93

  17. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison

    著者: , , , , , - BMJ Open 2019 被引用: 266

  18. Synovial tissue research: a state-of-the-art review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2017 被引用: 257

  19. The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis

    著者: , - Therapeutic Advances in Musculoskeletal Disease 2010 被引用: 364

  20. The role of sleep in pain and fibromyalgia

    著者: - Nature Reviews Rheumatology 2015 被引用: 326

  21. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen - Annals of the Rheumatic Diseases 2022 被引用: 69

  22. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claire Gorman, James Galloway, Hector Chinoy, Désirée van der Heijde, Peter Sasieni, Anne Barton, Costantino Pitzalis, Ahmed S Zayat, Ana Rita Marinho Machado, Andrea Cuervo, Arti Mahto, Cankut Çubuk, Charlotte Rawlings, Chijioke H Mosanya, Christopher D. Buckley, Chris Holroyd, Debbie Maskall, Francesco Carlucci, Georgina Thorborn, Gina Tan, Gloria Lliso-Ribera, Hasan Rizvi, Joanna Peel, João Eurico Fonseca, John D. Isaacs, Julio Ramírez, Laurent Méric de Bellefon, Liliane Fossati-Jimak, Mary Ng’endo Githinji, Mattia Congia, Neal L. Millar, Nirupam Purkayastha, Raquel Celis, Rakhi Seth, Rebecca Hands-Greenwood, Robert Landewé, Simone Perniola, Stefano Alivernini, Stefano Marcia, Stefano Marini, Stephen Kelly, Vasco C. Romão - The Lancet Rheumatology 2023 被引用: 68

  23. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)

    著者: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 128

  24. Transforming clinical trials in rheumatology: towards patient-centric precision medicine

    著者: , , - Nature Reviews Rheumatology 2020 被引用: 112